EN - Anglická CZ - Česká SK - Slovenská PL - Polská RO - Rumunská RU - Ruská TR - Turecká UA - Ukrajinská
EN - Anglická
  • CZ - Česká
  • SK - Slovenská
  • PL - Polská
  • RO - Rumunská
  • RU - Ruská
  • TR - Turecká
  • UA - Ukrajinská

MELOXICAM Bioveta 5 mg/ml solution for injection for dogs and cats

Homepage Products Veterinary products MELOXICAM Bioveta 5 mg/ml solution for injection for dogs and cats

Meloxicam in injectable form with rapid onset of analgesic and anti-inflammatory effects.

type of preparative: Other products
target species animals: Cat, Dog

Can we help you?

STATEMENT OF ACTIVE AND OTHER SUBSTANCES

Each ml contains:

Active substance:

Meloxicam 5 mg

Excipients:

Ethanol 96% (v/v)         159.74 mg

Clear, yellow or yellow-green solution.


INDICATIONS

Dogs:

Alleviation of inflammatory response and pain associated with acute and chronic involvement of the musculoskeletal system.

Alleviation of postoperative pain and inflammation after orthopedic surgeries and soft tissue surgeries.

Cats:

Alleviation of postoperative pain after ovarian hysterectomy and after minor soft tissue surgeries.


CONTRAINDICATIONS

Do not use in pregnant and lactating animals.

Do not use in animals suffering from disorders of the gastrointestinal tract, such as irritation and bleeding.

Do not use in animals with impaired hepatic, cardiac or renal function and haemorrhagic disorders.
Do not use in case of hypersensitivity to the active substance or to any of the excipients.

Do not use in animals less than 6 weeks of age and in cats weighing less than 2 kg.


ADVERSE REACTIONS

Typical adverse drug reactions of NSAIDs such as loss of appetite, vomiting, diarrhoea, faecal occult

blood, apathy and renal failure have occasionally been reported. Elevations in liver enzymes have been reported very rarely.

Hemorrhagic diarrhoea, haematemesis and gastrointestinal ulceration have been rarely observed in dogs.

These side effects occur in dogs generally within the first treatment week and are in most cases transient and disappear after termination of treatment. In very rare cases they may be serious or fatal.

In very rare cases a pseudo-anaphylactic reaction may occur, which should be treated symptomatically.

If adverse reactions occur, discontinue treatment and consult a veterinarian.

If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon.


TARGET SPECIES

Dogs and cats.


DOSAGE FOR EACH SPECIES, ROUTE AND METHOD OF ADMINISTRATION

Dogs

i) Musculoskeletal disorders 

Subcutaneous administration.

A single dose of 0.2 mg meloxicam/kg bw, corresponding to a dose of 0.4 ml of solution/10 kg bw.

To continue treatment, MELOXICAM Bioveta 1.5 mg/ml oral suspension can be used at a dose of 0.1 mg meloxicam/kg body weight, 24 hours after injection.

ii) Reduction of post-operative pain (over a period of 24 hours)

Intravenous or subcutaneous administration.

A single dose of 0.2 mg meloxicam/kg bw, corresponding to a dose of 0.4 ml of solution/10 kg bw.

Apply before surgery, for example at the time when anaesthesia is induced.

Cats

Reduction of post-operative pain

Subcutaneous administration.

A single dose of 0.3 mg meloxicam/kg bw, corresponding to a dose of 0.06 ml of solution/kg bw. Apply before surgery, for example at the time when anaesthesia is induced.


ADVICE ON CORRECT ADMINISTRATION

Avoid contamination when using this product.

Particular attention should be paid to accurate dosing.

The stopper can be punctured up to 50 times.         


WITHDRAWAL PERIOD

Not intended for food-producing animals.


SPECIAL STORAGE PRECAUTIONS

Keep out of the sight and reach of children.

Keep the immediate container in the carton in order to protect from light.

Protect from frost.

Do not use this veterinary medicinal product after the expiry date which is stated on the label and carton after EXP. The expiry date refers to the last day of that month.

Shelf life after first opening the immediate packaging: 28 days.


SPECIAL WARNINGS

Special precautions for use in animals:

Avoid use in any dehydrated, hypovolaemic or hypotensive animals as there is a potential risk of

increased renal toxicity.

Monitoring and hydration during anaesthesia should be part of standard practice.


Special precautions to be taken by the person administering the veterinary medicinal product to animals:

People with known hypersensitivity to NSAID should avoid contact with the veterinary medicinal product.

The veterinary medicinal product should not be administered by pregnant women.

Accidental self-injection may cause pain. 

In case of accidental self-injection seek medical advice immediately and show the package leaflet or label to a practitioner.

Wash your hands after using the product.


Pregnancy and lactation:

Safety of the veterinary medicinal product has not been determined for use during pregnancy and lactation.


Interaction with other medicinal products and other forms of interaction:

Other non-steroidal anti-inflammatory drugs (NSAIDs), diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects. The product must not be administered in conjunction with other NSAIDs or glucocorticoids. 

Concomitant use of potentially nephrotoxic drugs should be avoided. In animals with anaesthetic risks (e.g. in old animals), intravenous or subcutaneous administration of fluids should be considered during anaesthesia. The risk of altered renal function cannot be excluded with concomitant anaesthesia and NSAIDs.

Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects

and therefore a period without treatment with similar veterinary products should be observed for at least 24 hours before commencement of treatment.

The treatment-free period, however, should take into account the pharmacokinetic properties of the products used previously.


Overdose (symptoms, emergency procedures, antidotes):

Symptomatic treatment should be initiated in case of overdose.


Incompatibilities:

In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.


SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY

Medicines should not be disposed of via wastewater or household waste.

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.


OTHER INFORMATION

For animal treatment only.

Veterinary medicinal product subject to prescription.


PACKAGE SIZE

1 x 10 ml.


Contact us


antispam
Please fill in the text displayed in the picture

or call


+420 517 318 598